▲ Peaking
Health
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.
1 news trends Newsylist has tracked involving CNS — newest first.
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.